DRUGS

ESKESIA (Esketamine)

INN : Esketamine hydrochloride

Primary packaging : glass ampoule

Pharmaceutical form
Solution for injection/infusion

THERAPEUTIC INDICATIONS

ESKESIA® is used :

to initiate and perform general anaesthesia, as the only anaesthetic or possibly in combination with sleeping pills (hypnotics)
for anaesthesia and pain relief (analgesia) in emergency situations
for pain control in artificial respiration (intubation)
to supplement regional anaesthesia (local anaesthesia)

PHARMACEUTICAL FORM

Esketamine is available in glass ampoule.

PHARMACO-THERAPEUTIC CLASS

Others general anesthetics, ATC code : N01AX14.

Market authorization holder : International Drug Development

Market authorization operator : Laboratoires Chaix et du Marais

Product availability : 1er quarter 2022

PRACTICAL INFORMATION

Volume	Dosage	CIP Code	UCD Code	Box	Palett	Minimum order quantity
2 ml	50 mg	3400955073789	3400890018821	Box of 10 ampoules	-	Box of 10 ampoules
5 ml	25 mg	3400955073802	3400890018838	Box of 10 ampoules	-	Box of 10 ampoules
10 ml	250 mg	3400955073796	3400890018814	Box of 10 ampoules	-	Box of 10 ampoules

Product only available at the hospital